Technical Analysis for ARMP - Armata Pharmaceuticals, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Fell Below 200 DMA | Bearish | -9.25% | |
| Wide Bands | Range Expansion | -9.25% | |
| Upper Bollinger Band Touch | Strength | -9.25% | |
| 50 DMA Resistance | Bearish | -17.45% | |
| 200 DMA Support | Bullish | -17.45% | |
| New Uptrend | Bullish | -17.45% | |
| Calm After Storm | Range Contraction | -17.45% | |
| Inside Day | Range Contraction | -17.45% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | 3 days ago |
| Rose Above Upper Bollinger Band | 3 days ago |
| 50 DMA Resistance | 3 days ago |
| Up 5% | 3 days ago |
| Up 3% | 3 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Armata is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Armata's lead product candidate, AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. The Company is also developing and advancing a broad pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa, leveraging its proprietary phage-specific GMP manufacturing capabilities.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Antibiotics Bacteria Pseudomonas Staphylococcus Aureus Pathogenic Bacteria Drug Resistance Gram Negative Bacteria Manufacturing Capabilities Pseudomonas Aeruginosa Bacteriophage Multiple Drug Resistance
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Antibiotics Bacteria Pseudomonas Staphylococcus Aureus Pathogenic Bacteria Drug Resistance Gram Negative Bacteria Manufacturing Capabilities Pseudomonas Aeruginosa Bacteriophage Multiple Drug Resistance
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.2565 |
| 52 Week Low | 1.0701 |
| Average Volume | 14,927 |
| 200-Day Moving Average | 3.04 |
| 50-Day Moving Average | 3.23 |
| 20-Day Moving Average | 2.69 |
| 10-Day Moving Average | 2.82 |
| Average True Range | 0.36 |
| RSI (14) | 43.82 |
| ADX | 26.17 |
| +DI | 23.75 |
| -DI | 17.58 |
| Chandelier Exit (Long, 3 ATRs) | 2.38 |
| Chandelier Exit (Short, 3 ATRs) | 3.33 |
| Upper Bollinger Bands | 3.18 |
| Lower Bollinger Band | 2.20 |
| Percent B (%b) | 0.46 |
| BandWidth | 36.60 |
| MACD Line | -0.07 |
| MACD Signal Line | -0.14 |
| MACD Histogram | 0.065 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.21 | ||||
| Resistance 3 (R3) | 3.24 | 3.09 | 3.11 | ||
| Resistance 2 (R2) | 3.09 | 2.95 | 3.07 | 3.08 | |
| Resistance 1 (R1) | 2.87 | 2.86 | 2.80 | 2.84 | 3.05 |
| Pivot Point | 2.72 | 2.72 | 2.68 | 2.70 | 2.72 |
| Support 1 (S1) | 2.50 | 2.58 | 2.43 | 2.47 | 2.25 |
| Support 2 (S2) | 2.35 | 2.49 | 2.33 | 2.22 | |
| Support 3 (S3) | 2.13 | 2.35 | 2.19 | ||
| Support 4 (S4) | 2.10 |
